Literature DB >> 11429224

Implications of quantitative tumor and nodal regression rates for nasopharyngeal carcinomas after 45 Gy of radiotherapy.

F M Fang1, W L Tsai, S F Go, M W Ho, J M Wu, C J Wang, C Y Su, W C Chen, E Y Huang.   

Abstract

PURPOSE: To quantitatively investigate the clinical implications of tumor regression rate (TRR-45) and nodal regression rate (NRR-45) of nasopharyngeal carcinomas (NPC) after receiving 45 Gy of radiotherapy (RT). The values, predictive values, and associated factors of TRR-45 and NRR-45 in NPC are analyzed. METHODS AND MATERIALS: One hundred one patients with newly diagnosed NPC and who were curatively treated by RT alone were included in the study. Tumor volume and nodal volume before treatment and after 45 Gy were obtained from computed tomographic (CT) scans performed at those times and calculated with the assistance of a computer-based imaging analyzing system. TRR-45 (NRR-45) was defined as the ratio of reduced tumor (nodal) volume after 45 Gy to the initial tumor (nodal) volume. TRR-45 (NRR-45) values were stratified into three groups of slow (below 50%), moderate (between 50% and 75%), and rapid (above 75%) change. After conventional RT with 45 Gy, conformal RT for primary tumors was boosted to 70.2-72 Gy for T1-2 tumors, and 75.6-81 Gy for T3-T4 tumors. RT for residual neck masses was boosted by electron beam to 61-75 Gy.
RESULTS: The mean value of TRR-45 for all patients was lower than that of NRR-45 for the 78 patients with metastatic neck nodes (70% +/- 4.8% vs. 81% +/- 5%, p = 0.003). The 3-year actuarial neck control rate was better than the primary tumor control rate with statistical significance (98% vs. 85%, p = 0.009). No significant statistical differences concerning local control probability, nodal control probability, or survival rate were found among patients with slow, moderate, or rapid TRR-45 or NRR-45. T-stage was the only significant prognostic factor for locoregional control after multivariate analysis. Tumor volume and T-stage were found to have a statistically significant negative correlation with TRR-45. No associated factor was found to be significantly correlated with NRR-45.
CONCLUSION: Slow regression rates of the primary tumor or neck nodes in NPC after receiving 45 Gy of irradiation do not mean ultimately poor radiocurability, but may merely imply slow clearance of the cells damaged during irradiation. The different radiobiological behaviors of the regression rates during treatment, ultimate control probabilities, or associated factors for regression rates of NPC between primary tumors and neck nodes need to be further investigated.

Entities:  

Mesh:

Year:  2001        PMID: 11429224     DOI: 10.1016/s0360-3016(01)01531-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

1.  Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer.

Authors:  Charles B Simone; David Ly; Tu D Dan; John Ondos; Holly Ning; Arnaud Belard; John O'Connell; Robert W Miller; Nicole L Simone
Journal:  Radiother Oncol       Date:  2011-06-12       Impact factor: 6.280

2.  Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes?

Authors:  Tzu-Chen Yen; Yu-Chen Chang; Sheng-Chieh Chan; Joseph Tung-Chieh Chang; Ching-Han Hsu; Kun-Ju Lin; Wuu-Jyh Lin; Ying-Kai Fu; Shu-Hang Ng
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12-30       Impact factor: 9.236

3.  FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway.

Authors:  Chang-Han Chen; Li-Yen Shiu; Li-Jen Su; Chi-Ying F Huang; Shun-Chen Huang; Chao-Cheng Huang; Yu-Fang Yin; Wei-Sheng Wang; Hsin-Ting Tsai; Fu-Min Fang; Wan-Chu Chuang; Hong-Chang Kang; Chung-Feng Hwang
Journal:  J Transl Med       Date:  2012-05-16       Impact factor: 5.531

4.  Loss of epithelial membrane protein-2 expression confers an independent prognosticator in nasopharyngeal carcinoma: a cohort study.

Authors:  Yi-Hsien Chen; Li-Ching Wu; Wen-Ren Wu; Hung-Jung Lin; Sung-Wei Lee; Ching-Yih Lin; Shih-Lun Chang; Nan-Haw Chow; Hsuan-Ying Huang; Chien-Feng Li; Han-Ping Hsu; Yow-Ling Shiue
Journal:  BMJ Open       Date:  2012-04-05       Impact factor: 2.692

5.  Regression rate of posterior uveal melanomas following iodine-125 plaque radiotherapy.

Authors:  Hakan Demirci; Fiorella Saponara; Adam Khan; Leslie M Niziol; Choonik Lee; James A Hayman; Grant Comer; David C Musch
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Jan-Mar

6.  A retrospective study of the prognostic value of MRI-derived residual tumors at the end of intensity-modulated radiotherapy in 358 patients with locally-advanced nasopharyngeal carcinoma.

Authors:  Yuxiang He; Qin Zhou; Lin Shen; Yajie Zhao; Mingjun Lei; Rui Wei; Liangfang Shen; Shousong Cao
Journal:  Radiat Oncol       Date:  2015-04-15       Impact factor: 3.481

7.  Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis.

Authors:  Chung-Feng Hwang; Li-Yen Shiu; Li-Jen Su; Wei-Sheng Wang; Shun-Chen Huang; Tai-Jan Chiu; Chao-Cheng Huang; Yen-Yi Zhen; Hsin-Ting Tsai; Fu-Min Fang; Tai-Lin Huang; Chang-Han Chen
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

8.  Recent advances in image-guided radiotherapy for head and neck carcinoma.

Authors:  Sameer K Nath; Daniel R Simpson; Brent S Rose; Ajay P Sandhu
Journal:  J Oncol       Date:  2009-07-29       Impact factor: 4.375

9.  Developing an adaptive radiation therapy strategy for nasopharyngeal carcinoma.

Authors:  Winky Wing Ki Fung; Vincent Wing Cheung Wu; Peter Man Lung Teo
Journal:  J Radiat Res       Date:  2013-08-29       Impact factor: 2.724

10.  Using neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma with intracranial invasion to protect critical normal tissue.

Authors:  Xiaoshuang Niu; Xi Chang; Yunsheng Gao; Chaosu Hu; Lin Kong
Journal:  Radiat Oncol       Date:  2013-10-02       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.